Quantcast
Home > Quotes > TBIO
TBIO

Translate Bio, Inc. Common Stock (TBIO) Quote & Summary Data

$8.7
*  
0.25
2.96%
Get TBIO Alerts
*Delayed - data as of Feb. 22, 2019  -  Find a broker to begin trading TBIO now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
1 Year Target
23
Today's High / Low
$ 9.33 / $ 8
Share Volume
1,263,524
50 Day Avg. Daily Volume
118,286
Previous Close
$ 8.45
52 Week High / Low
$ 16.60 / $ 4.81
Market Cap
392,736,183
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
0

Intraday Chart

Shares Traded

Share Volume:
1,263,524
50 Day Avg. Daily Volume:
118,286

Trading Range

The current last sale of $8.70 is 80.87% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 9.33 $ 16.60
 Low: $ 8 $ 4.81

Company Description (as filed with the SEC)

We are a leading messenger RNA, or mRNA, therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction. Using our proprietary mRNA therapeutic platform, or MRT platform, we create mRNA that encodes functional proteins. We believe that the mRNA design, delivery and manufacturing capabilities of our MRT platform provide us with the most advanced platform for developing product candidates that deliver mRNA encoding functional proteins for therapeutic uses. Our mRNA is delivered to the target cell where the cell's own machinery recognizes it and translates it, restoring or augmenting protein function to treat or prevent disease. We believe that our MRT platform is broadly applicable across multiple diseases in which the production of a desirable protein can have a therapeutic effect.  ... More ...  


Risk Grade

Where does TBIO fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 8.47
Open Date:
Feb. 22, 2019
Close Price:
$ 8.70
Close Date:
Feb. 22, 2019

Consensus Recommendation

Analyst Info